" /> Romlusevimab - CISMeF





Preferred Label : Romlusevimab;

NCIt synonyms : Anti-SARS-CoV-2 Spike Protein Monoclonal Antibody BRII-198; Monoclonal Antibody BRII-198; Anti-SARS-CoV-2 S Protein Monoclonal Antibody BRII-198;

NCIt definition : A neutralizing human monoclonal antibody, isolated from a patient who has recovered from the Coronavirus disease 2019 (COVID-19), directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for passive immunization against COVID-19. Upon administration, romlusevimab specifically targets and binds to a specific epitope on the SARS-CoV-2 S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.;

UNII : SM01RRU9KK;

CAS number : 2509447-08-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2509447-08-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : BRII 198; BRII-198;

NCI Metathesaurus CUI : CL1412583;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
22/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.